● Preparing manuscripts for publication in leading cancer or oncology journals, with a special interest in publication of pre-clinical research● Writing continuing medical education (CME) needs assessments and educational content● Copy-editing, writing, and scientific review of manuscripts, grants, and presentations for academic investigators● Fact-checking across document types (i.e., clinical or pre-clinical manuscripts, abstracts, posters, slide decks, etc.) and therapeutic areas● Support for individual tasks (i.e., slide formatting, collecting references, document updates with recent developments, etc.) as needed to enable client's focus on most important projects● Deep expertise in Oncology, Immuno-Oncology, and Preclinical Sciences. Additional areas of writing experience include (but not limited to) Hematology, Neurology, Rheumatology, Cardiology, Rare Diseases, and others● Consistent attention to ensuring that writing meets the needs of both the client and audience ● Invested in working to provide support that will deliver clinically meaningful impact to improve outcomes for patients with cancer● Accepting limited projects from new clients. For more information, please visit www.markantmedical.com or email smarkant@markantmedical.com

● Crafted effective needs assessments for continuing medical education grant proposals across a range of therapeutic areas, including oncology, dermatology, gastroenterology, cardiology, and pulmonology.● Performed analyses of gaps in clinician education and competence based on review of literature, surveys, and prior outcomes reports.● Effectively communicated within and across teams to transfer medical research knowledge gained during grant development.

● Interacted with a diverse array of veterinary clinical and basic researchers to identify novel approaches for treating canine and human lymphomas.● Presented research updates to audiences of differing knowledge levels.● Mentored undergraduate students and junior scientists.

● Managed a small team of scientists responsible for evaluating immune system modulators as anti-cancer therapies.● Utilized adoptive transfer of T cells isolated from healthy human donors into tumor-bearing mice to assess a portfolio of bispecific antibody therapeutics.● Interacted with broader multidisciplinary teams to execute complex in vivo projects within rigid time frames.● Communicated frequent project status updates to team leaders to ensure optimal decision-making and rapid advancement of potential therapies.

● Prepared written reports and oral presentations to provide the departmental team and leadership with project status updates.● Investigated epigenetic-mediated mechanisms of resistance to therapy in lung and breast cancer using CRISPR-mediated gene modulation and small molecule approaches.● Evaluated the tumorigenic potential of subpopulations of cells from patient-derived xenografts of human colorectal cancer.

● Edited grammar and language in scientific manuscripts written by non-native English speakers.● Provided summary reports to inform clients of editing changes made and best practices in writing.● Improved the ability of authors to effectively communicate their results, enabling publication in leading scientific and medical journals.

● Continued PhD thesis research begun at Duke University upon relocation of the lab to the Sanford-Burnham Medical Research Institute in La Jolla, CA.

● Effectively communicated research proposals and results through manuscripts, literature reviews, grant proposals, poster presentations, and oral slide presentations.● Mentored 3 research technicians and 1 undergraduate student, supporting their growth as scientists.● Used genetically engineered mouse models, lentiviral-mediated gene delivery, and small molecule approaches to identify potential therapeutic targets in tumor-propagating cells from medulloblastoma, a type of pediatric brain tumor.● Generated medulloblastoma patient-derived xenografts and used them to perform preclinical studies in specific tumor subtypes. ● Utilized immunohistological analyses of genetically engineered mouse models to demonstrate that CXCR4 is required for the migration of granule neuron precursors during postnatal cerebellar development.

● Validated potential cancer therapeutic targets using RNAi approaches in panel of >100 cancer cell lines. ● Optimized bioluminescence imaging strategies for evaluating the in vivo role of potential targets. ● Investigated the role and signaling capacity of a tyrosine kinase receptor of unknown function in cancer. ● Identified PI3K pathway activation as a mechanism for tumor resistance to HER2-targeted therapy. ● Developed target biology-directed assays for advancing therapeutic antibodies against Notch receptors. ● Prepared PowerPoint slide presentations to provide research updates to the project teams.

● Characterized products of substrate cleavage by the aminopeptidase ERAP1 using HPLC. ● Studied the role of the ubiquitin ligase Nrdp1 and its substrate BRUCE/appollon. ● Managed lab maintenance activities (including supply ordering, equipment upkeep, and adherence to safety requirements) for a lab of approximately 20 scientists.

● Performed cloning/protein purification of mammalian Phospholipase D; assisted lab members with individual projects.

● Investigated muscarinic receptor localization in sublingual acini isolated from adult rats using immunofluorescence/histological approaches. ● Established PCR-based protocol for mapping the mutation resulting in sublingual deficiency in mice. ● Position covered summer and winter college breaks.